$AMED
AMEDISYS INC

2019 Q2 Form 10-Q Financial Statement

#000089626219000011 Filed on August 01, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $493.0M $411.6M
YoY Change 19.78% 9.79%
Cost Of Revenue $290.8M $242.6M
YoY Change 19.85% 10.0%
Gross Profit $202.2M $169.0M
YoY Change 19.64% 9.46%
Gross Profit Margin 41.01% 41.06%
Selling, General & Admin $152.3M $123.1M
YoY Change 23.72% 1.82%
% of Gross Profit 75.32% 72.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.200M $3.100M
YoY Change 67.74% -32.61%
% of Gross Profit 2.57% 1.83%
Operating Expenses $157.4M $126.2M
YoY Change 24.72% 0.56%
Operating Profit $44.80M $42.80M
YoY Change 4.67% 17733.33%
Interest Expense $4.332M $2.140M
YoY Change 102.43% 78.78%
% of Operating Profit 9.67% 5.0%
Other Income/Expense, Net -$403.0K $1.309M
YoY Change -130.79% -43.72%
Pretax Income $44.35M $44.14M
YoY Change 0.48% 1620.07%
Income Tax $10.31M $10.60M
% Of Pretax Income 23.24% 24.01%
Net Earnings $33.70M $33.30M
YoY Change 1.2% 640.0%
Net Earnings / Revenue 6.84% 8.09%
Basic Earnings Per Share $1.05 $1.00
Diluted Earnings Per Share $1.02 $0.98
COMMON SHARES
Basic Shares Outstanding 32.08M shares 33.44M shares
Diluted Shares Outstanding 32.93M shares 34.18M shares

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.90M $25.90M
YoY Change -46.33% -56.25%
Cash & Equivalents $13.90M $25.90M
Short-Term Investments
Other Short-Term Assets $13.25M $24.78M
YoY Change -46.53% -38.96%
Inventory
Prepaid Expenses $8.957M $10.49M
Receivables $239.7M $197.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $275.8M $258.8M
YoY Change 6.57% -5.25%
LONG-TERM ASSETS
Property, Plant & Equipment $29.76M $28.00M
YoY Change 6.29% -18.6%
Goodwill $664.8M $324.1M
YoY Change 105.1%
Intangibles $61.97M $44.89M
YoY Change 38.05%
Long-Term Investments
YoY Change
Other Assets $58.29M $50.60M
YoY Change 15.19% -63.62%
Total Long-Term Assets $930.1M $494.6M
YoY Change 88.06% -7.18%
TOTAL ASSETS
Total Short-Term Assets $275.8M $258.8M
Total Long-Term Assets $930.1M $494.6M
Total Assets $1.206B $753.3M
YoY Change 60.07% -6.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $35.69M $29.81M
YoY Change 19.72% 2.44%
Accrued Expenses $131.9M $96.47M
YoY Change 36.68% -48.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $7.600M $700.0K
YoY Change 985.71% -91.36%
Total Short-Term Liabilities $313.0M $214.2M
YoY Change 46.14% -4.93%
LONG-TERM LIABILITIES
Long-Term Debt $266.5M $123.9M
YoY Change 115.09% 48.92%
Other Long-Term Liabilities $6.053M $6.137M
YoY Change -1.37% 42.72%
Total Long-Term Liabilities $272.6M $130.0M
YoY Change 109.6% 56.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $313.0M $214.2M
Total Long-Term Liabilities $272.6M $130.0M
Total Liabilities $642.9M $344.3M
YoY Change 86.75% 9.71%
SHAREHOLDERS EQUITY
Retained Earnings $184.6M $60.71M
YoY Change 204.05%
Common Stock $623.3M $585.1M
YoY Change 6.52%
Preferred Stock
YoY Change
Treasury Stock (at cost) $246.2M $237.9M
YoY Change 3.46%
Treasury Stock Shares 4.315M shares 4.243M shares
Shareholders Equity $561.8M $408.0M
YoY Change
Total Liabilities & Shareholders Equity $1.206B $753.3M
YoY Change 60.07% -6.52%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income $33.70M $33.30M
YoY Change 1.2% 640.0%
Depreciation, Depletion And Amortization $5.200M $3.100M
YoY Change 67.74% -32.61%
Cash From Operating Activities $59.20M $50.70M
YoY Change 16.77% 40.06%
INVESTING ACTIVITIES
Capital Expenditures -$1.500M -$100.0K
YoY Change 1400.0% -96.67%
Acquisitions
YoY Change
Other Investing Activities -$17.60M -$1.800M
YoY Change 877.78% -91.09%
Cash From Investing Activities -$19.10M -$2.000M
YoY Change 855.0% -91.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -36.90M -142.8M
YoY Change -74.16% 6700.0%
NET CHANGE
Cash From Operating Activities 59.20M 50.70M
Cash From Investing Activities -19.10M -2.000M
Cash From Financing Activities -36.90M -142.8M
Net Change In Cash 3.200M -94.10M
YoY Change -103.4% -963.3%
FREE CASH FLOW
Cash From Operating Activities $59.20M $50.70M
Capital Expenditures -$1.500M -$100.0K
Free Cash Flow $60.70M $50.80M
YoY Change 19.49% 29.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
amed Episode Of Care As Episodic Based Revenue Duration
EpisodeOfCareAsEpisodicBasedRevenueDuration
P60D
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 visit
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98
amed Net Service Revenue Episode Payment Rate Duration
NetServiceRevenueEpisodePaymentRateDuration
P60D
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 visit
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 visit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0000896262
dei Entity Registrant Name
EntityRegistrantName
AMEDISYS INC
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
95472000 USD
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
98936000 USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36252280 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36445591 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31973505 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32130184 shares
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33050000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
35402000 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4278775 shares
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
4315407 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-24260
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-3131700
dei Entity Address Address Line1
EntityAddressAddressLine1
3854 American Way
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
Baton Rouge
dei Entity Address State Or Province
EntityAddressStateOrProvince
LA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
70816
dei City Area Code
CityAreaCode
225
dei Local Phone Number
LocalPhoneNumber
292-2031
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
AMED
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32174921 shares
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q2 us-gaap Goodwill
Goodwill
664822000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
329480000 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
61966000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
44132000 USD
CY2019Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
30213000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13902000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20229000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
239674000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
188972000 USD
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8957000 USD
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7568000 USD
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
13252000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7349000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
275785000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
224118000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29762000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29449000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
85026000 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
35794000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58288000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
54145000 USD
CY2019Q2 us-gaap Assets
Assets
1205862000 USD
CY2018Q4 us-gaap Assets
Assets
717118000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
35690000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
28531000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
111660000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
92858000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
131860000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
99475000 USD
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
7610000 USD
CY2018Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1612000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26187000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
313007000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
222476000 USD
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
266468000 USD
CY2018Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5775000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
57392000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q2 us-gaap Minority Interest
MinorityInterest
1161000 USD
CY2018Q4 us-gaap Minority Interest
MinorityInterest
1051000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
562942000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
482633000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1205862000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
717118000 USD
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6053000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6234000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
642920000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
234485000 USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2018Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2019Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
36000 USD
CY2018Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
36000 USD
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
623309000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
603666000 USD
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
246175000 USD
CY2018Q4 us-gaap Treasury Stock Value
TreasuryStockValue
241685000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
184596000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
119550000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
561781000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
481582000 USD
CY2019Q2 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
492984000 USD
CY2018Q2 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
411603000 USD
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
960324000 USD
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
810865000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
290752000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
242564000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
566026000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
480873000 USD
CY2019Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
98356000 USD
CY2018Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
77215000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
193186000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
152846000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5538000 USD
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3767000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12153000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7811000 USD
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2976000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4932000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4836000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
193000 USD
CY2019Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
48408000 USD
CY2018Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
42104000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
91810000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
83784000 USD
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5179000 USD
CY2018Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3125000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8074000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6718000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
448233000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
368775000 USD
us-gaap Costs And Expenses
CostsAndExpenses
871249000 USD
us-gaap Costs And Expenses
CostsAndExpenses
732032000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
44751000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
42828000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
89075000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
78833000 USD
CY2019Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
20000 USD
CY2018Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
114000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
44000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
234000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
4332000 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
2140000 USD
us-gaap Interest Expense
InterestExpense
7681000 USD
us-gaap Interest Expense
InterestExpense
3843000 USD
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3716000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
359000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
429000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
960000 USD
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-403000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1309000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2276000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2187000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44348000 USD
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
44137000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
86799000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81020000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10308000 USD
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10596000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21186000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33705000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20159000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
34040000 USD
CY2018Q2 us-gaap Profit Loss
ProfitLoss
33541000 USD
us-gaap Profit Loss
ProfitLoss
65613000 USD
us-gaap Profit Loss
ProfitLoss
60861000 USD
CY2019Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
298000 USD
CY2018Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
192000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
567000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
353000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
33742000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
33349000 USD
us-gaap Net Income Loss
NetIncomeLoss
65046000 USD
us-gaap Net Income Loss
NetIncomeLoss
60508000 USD
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.80
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32075000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33439000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32038000 shares
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.76
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32933000 shares
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34179000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32913000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34391000 shares
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
521200000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
752000 USD
CY2019Q2 amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
2318000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
987000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5538000 USD
CY2019Q2 amed Surrendered Shares
SurrenderedShares
1802000 USD
CY2019Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
91000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
34040000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
562942000 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
549558000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
560000 USD
CY2018Q2 amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
2402000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2484000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3767000 USD
CY2018Q2 amed Surrendered Shares
SurrenderedShares
1527000 USD
CY2018Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
181402000 USD
CY2018Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
322000 USD
CY2018Q2 us-gaap Profit Loss
ProfitLoss
33541000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
409061000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
482633000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1534000 USD
amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
4613000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1343000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12153000 USD
amed Surrendered Shares
SurrenderedShares
4490000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
457000 USD
us-gaap Profit Loss
ProfitLoss
65613000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
562942000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
516426000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1157000 USD
amed Stock Issued During Period Value Four Zero One K Employer Match
StockIssuedDuringPeriodValueFourZeroOneKEmployerMatch
4781000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2609000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7811000 USD
amed Surrendered Shares
SurrenderedShares
2832000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
181402000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
350000 USD
us-gaap Profit Loss
ProfitLoss
60861000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
409061000 USD
us-gaap Profit Loss
ProfitLoss
65613000 USD
us-gaap Profit Loss
ProfitLoss
60861000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8074000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6718000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12153000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7811000 USD
us-gaap Pension Expense
PensionExpense
4686000 USD
us-gaap Pension Expense
PensionExpense
4894000 USD
amed Amortizationand Impairmentof Operating Lease Right Of Use Asset
AmortizationandImpairmentofOperatingLeaseRightOfUseAsset
17495000 USD
amed Amortizationand Impairmentof Operating Lease Right Of Use Asset
AmortizationandImpairmentofOperatingLeaseRightOfUseAsset
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-650000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5875000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9145000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4932000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4836000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
433000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
355000 USD
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 USD
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
38000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
842000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2204000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24165000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3604000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8343000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11680000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
56000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-688000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9475000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3623000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
29262000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4548000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-181000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2347000 USD
amed Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-16200000 USD
amed Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 USD
amed Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1754000 USD
amed Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
79325000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
90970000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
213000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
471000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
146000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
11000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
210000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2693000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1611000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
345414000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4074000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-347958000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5203000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1343000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2609000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1534000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1157000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4490000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2832000 USD
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
457000 USD
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
350000 USD
amed Proceeds From Borrowings Under Term Loan
ProceedsFromBorrowingsUnderTermLoan
175000000 USD
amed Proceeds From Borrowings Under Term Loan
ProceedsFromBorrowingsUnderTermLoan
0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
184500000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
127500000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
92000000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2277000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
90475000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
847000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2433000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
181402000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
262306000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-146226000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6327000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-60459000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20229000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86363000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13902000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25904000 USD
us-gaap Interest Paid
InterestPaid
4187000 USD
us-gaap Interest Paid
InterestPaid
2080000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7849000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6149000 USD
CY2019Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
38 state
us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our accounting and reporting policies conform with U.S. GAAP. In preparing the unaudited condensed consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
CY2019Q2 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.50
CY2019Q2 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.50
CY2019Q2 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
39400000 USD
CY2018Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
35100000 USD
CY2019Q2 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.20
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99
CY2019Q2 amed Revenuebypayorclassasapercentageoftotalnetservicerevenue
Revenuebypayorclassasapercentageoftotalnetservicerevenue
1
CY2018Q2 amed Revenuebypayorclassasapercentageoftotalnetservicerevenue
Revenuebypayorclassasapercentageoftotalnetservicerevenue
1
amed Revenuebypayorclassasapercentageoftotalnetservicerevenue
Revenuebypayorclassasapercentageoftotalnetservicerevenue
1
amed Revenuebypayorclassasapercentageoftotalnetservicerevenue
Revenuebypayorclassasapercentageoftotalnetservicerevenue
1
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.10
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
4 visit
CY2019Q2 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98
CY2018Q2 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.10
CY2019Q2 amed Accounts Receivable Portion Derived From Medicare
AccountsReceivablePortionDerivedFromMedicare
0.59
CY2018Q4 amed Accounts Receivable Portion Derived From Medicare
AccountsReceivablePortionDerivedFromMedicare
0.56
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99
amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.60
amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.50
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120 day
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60 day
CY2019Q1 us-gaap Debt Issuance Costs Line Of Credit Arrangements Gross
DebtIssuanceCostsLineOfCreditArrangementsGross
800000 USD
CY2019Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
4000000.0 USD
CY2018Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
3500000 USD
CY2019Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
200000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
400000 USD
CY2019Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
4000000.0 USD
amed Unamortized Debt Issuance Cost Amortization Period
UnamortizedDebtIssuanceCostAmortizationPeriod
P4Y7M6D
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34179000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32913000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34391000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
159000 shares
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
57000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
143000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
88000 shares
CY2019Q2 amed Debt Instrument Carrying Amount Excluding Capital Leases
DebtInstrumentCarryingAmountExcludingCapitalLeases
274800000 USD
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32075000 shares
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33439000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32038000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33705000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
537000 shares
CY2018Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
425000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
548000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
381000 shares
CY2019Q2 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
321000 shares
CY2018Q2 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
315000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
327000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
305000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32933000 shares
CY2019Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2019Q2 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P3Y
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
9000000.0 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
17200000 USD
CY2019Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
200000 USD
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
300000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
9200000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
17500000 USD
CY2019Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
400000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
800000 USD
CY2019Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
100000 USD
CY2019Q2 amed Finance Lease Cost
FinanceLeaseCost
400000 USD
amed Finance Lease Cost
FinanceLeaseCost
900000 USD
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
700000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
1200000 USD
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
10300000 USD
us-gaap Lease Cost
LeaseCost
19700000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
85000000.0 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26200000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
57400000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
83600000 USD
CY2019Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
4400000 USD
CY2019Q2 amed Lessee Financeleases Accumulated Amortization
LesseeFinanceleasesAccumulatedAmortization
1100000 USD
CY2019Q2 amed Financelease Rightof Use Asset Net
FinanceleaseRightofUseAssetNet
3300000 USD
CY2019Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1500000 USD
CY2019Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1800000 USD
CY2019Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
3300000 USD
CY2019Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.041
CY2019Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.053
us-gaap Operating Lease Payments
OperatingLeasePayments
18000000.0 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
800000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
102200000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1800000 USD
amed Lessee Operatinglease Reductionsto Ro Uassetsresultingfromreductionstoleaseobligations
LesseeOperatingleaseReductionstoROUassetsresultingfromreductionstoleaseobligations
900000 USD
amed Lessee Financelease Reductionto Ro Uassetsresultingfromreductionstoleaseobligations
LesseeFinanceleaseReductiontoROUassetsresultingfromreductionstoleaseobligations
0 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
14100000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
800000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
27500000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1500000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
19800000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1100000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11400000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
100000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
7600000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
10700000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2019Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
7600000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1600000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
91100000 USD
CY2019Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
3500000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7500000 USD
CY2019Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
200000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
83600000 USD
CY2019Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
3300000 USD
CY2019Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
278100000 USD
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10900000 USD
CY2019Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
4000000.0 USD
CY2018Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3500000 USD
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
274100000 USD
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
7400000 USD
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
266500000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5800000 USD
CY2019Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
725000000.0 USD
CY2019Q2 amed Total Leverage Ratio
TotalLeverageRatio
1.2
CY2019Q2 amed Consolidated Interest Coverage Ratio
ConsolidatedInterestCoverageRatio
18.0
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
1300000 USD
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
1000000.0 USD
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segments
CY2018Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3100000 USD
CY2019Q2 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
493000000.0 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
152300000 USD
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5200000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
448200000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
44800000 USD
CY2018Q2 us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
411600000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
242600000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
123100000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
368800000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
42800000 USD
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
960300000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
566000000.0 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
297100000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8100000 USD
us-gaap Costs And Expenses
CostsAndExpenses
871200000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
89100000 USD
us-gaap Health Care Organization Revenue Net Of Patient Service Revenue Provisions
HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions
810900000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
480900000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244500000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6700000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
78800000 USD
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 USD
CY2019Q1 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2020-03-01

Files In Submission

Name View Source Status
0000896262-19-000011-index-headers.html Edgar Link pending
0000896262-19-000011-index.html Edgar Link pending
0000896262-19-000011.txt Edgar Link pending
0000896262-19-000011-xbrl.zip Edgar Link pending
amed-20190630.xsd Edgar Link pending
amed-20190630_cal.xml Edgar Link unprocessable
amed-20190630_def.xml Edgar Link unprocessable
amed-20190630_lab.xml Edgar Link unprocessable
amed-20190630_pre.xml Edgar Link unprocessable
amed-20193006x10xq.htm Edgar Link pending
amed-20193006x10xq_htm.xml Edgar Link completed
amed-20193006xexx311.htm Edgar Link pending
amed-20193006xexx312.htm Edgar Link pending
amed-20193006xexx321.htm Edgar Link pending
amed-20193006xexx322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending